The majority of these results of drug resistance were from in vitro studies, whereas clinical data was available only in ovarian cancers where high lncRNA UCA1 expression was associated with the response to platinum-based chemotherapy [74]. This evidence concerns the gene UCA1 and ovarian carcinoma.